Oct 29 (Reuters) - Pfizer Inc reported better-than-expected third-quarter earnings on Tuesday, helped by costs cuts and growing sales of recently approved cancer medicines.

from Reuters: Financial Services and Real Estate http://feeds.reuters.com/~r/reuters/financialServicesRealEstateNews/~3/4BJxG1yWKWY/story01.htm
from Reuters: Financial Services and Real Estate http://feeds.reuters.com/~r/reuters/financialServicesRealEstateNews/~3/4BJxG1yWKWY/story01.htm
Tidak ada komentar:
Posting Komentar